A life sciences company in Deeside, north Wales, has launched an innovative robotic system aimed at transforming diagnostic technologies. Biofortuna has developed the BeadBot with a funding boost of £225,000 from the Welsh Government’s SMART Flexible Innovation Support (SFIS) scheme. This new system is designed to automate the production of lyophilised (freeze-dried) reagent beads, which are essential components in diagnostic devices that test for conditions such as cancer.
Rebecca Evans, the cabinet secretary for economy, energy, and planning, commented on the initiative, stating, “We are committed to fostering a culture of innovation which will improve the lives of people across Wales.” She highlighted the intention to build a Welsh economy that is focused on future industries and services. According to Evans, the pioneering processing system from Biofortuna is expected to significantly boost productivity, enhance the company’s market position, and ultimately protect existing skilled jobs while generating demand for new roles.
The BeadBot system addresses specific production challenges within Biofortuna’s processes, particularly a complex packing stage currently performed by qualified scientists. This automation is anticipated to streamline manufacturing operations and enable the company to capture a larger share of the expanding global market for lyophilised reagent beads.
Dr. Nick Leaves, chief operating officer at Biofortuna, expressed gratitude for the support from the Welsh Government, noting that it has been crucial in bringing the robotic system to fruition. “The Welsh Government’s SFIS support will help us significantly increase our manufacturing capacity, accelerating market penetration in a rapidly growing and essential segment of the diagnostics market,” he said, emphasizing the collaborative potential of government and industry efforts.
The funding for Biofortuna is part of a broader initiative launched in 2023 by the Welsh Government, which has allocated £20 million to support research and innovation initiatives addressing societal and environmental challenges. To date, £17.9 million has been distributed to various companies, including Biofortuna, to aid in the development of new research and development solutions.
In addition to the funding for BeadBot, Biofortuna has secured £4.7 million in export contracts with the assistance of Welsh Government programmes. The company anticipates that the introduction of BeadBot will further propel its international growth.
Biofortuna is among 140 projects benefiting from the SMART innovation funding, with its award being a notable example of how targeted financial support can drive technological advancements in the life sciences sector. As the company continues to innovate, it reinforces Wales’ reputation for excellence in both the life sciences and advanced manufacturing industries.
